| Ayesha L Boger, ALC, MFT | |
|
2558 Ross Clark Cir Ste 113, Dothan, AL 36301-4970 | |
| (334) 575-3009 | |
| (334) 829-5429 |
| Full Name | Ayesha L Boger |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 2558 Ross Clark Cir Ste 113, Dothan, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063051217 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 04834 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ayesha L Boger, ALC, MFT 312 Gwinnett Pl, Dothan, AL 36301-4933 Ph: (334) 790-3600 | Ayesha L Boger, ALC, MFT 2558 Ross Clark Cir Ste 113, Dothan, AL 36301-4970 Ph: (334) 575-3009 |
News Archive
University of Texas at Dallas researchers have designed a wearable device that monitors sweat for biomarkers that could signal flare-ups of inflammatory bowel disease (IBD).
Inhibitex, Inc. today announced that its collaborator, Pfizer, Inc., has initiated patient recruitment for 408-patient, randomized, double-blind Phase I clinical trial to evaluate the safety, tolerability, and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus (S. aureus) vaccine (SA3Ag) in healthy adults.
People with primary immunodeficiency diseases (PIDD) and their families will now be able to connect with one another and share their experiences through a new multidimensional social networking initiative, the Immune Deficiency Foundation (IDF) announced today. Primary immunodeficiency diseases are a group of rare, chronic illnesses, caused by hereditary or genetic defects in the immune system.
Emergent BioSolutions Inc. announced today that its investigational anthrax vaccine, NuThrax, has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA).
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.
› Verified 8 days ago
Mr. Bradford Lee Bullard, LIC PROFESSIONAL COU Counselor Medicare: Not Enrolled in Medicare Practice Location: 187 Belmont Drive, Dothan, AL 36305 Phone: 334-671-1280 Fax: 334-671-0475 | |
Mrs. Lori Lynn Chancy, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 Fax: 334-712-0972 | |
Mary J Strother, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 Fax: 334-712-0972 | |
Mrs. Emrist Anne Mustin, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 | |
Donda Goodson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 Preswick Dr, Dothan, AL 36305 Phone: 334-790-8362 | |
Mrs. Kimberly Andrews Caton, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 172 Belmont Dr, Dothan, AL 36305 Phone: 334-671-1280 Fax: 334-671-0475 | |
Mrs. Terry Denise Bradley, MS, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2431 W Main St, Suite 603, Dothan, AL 36301 Phone: 334-673-8869 Fax: 334-673-8851 |